Skip to main content
Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
1.650
+0.220 (15.38%)
At close: Mar 9, 2026, 4:00 PM EDT
1.650
0.00 (0.00%)
After-hours: Mar 9, 2026, 5:52 PM EDT

Treace Medical Concepts Revenue

In the year 2025, Treace Medical Concepts had annual revenue of $212.69M with 1.59% growth. Treace Medical Concepts had revenue of $62.52M in the quarter ending December 31, 2025, a decrease of -9.01%.

Revenue (ttm)
$212.69M
Revenue Growth
+1.59%
P/S Ratio
0.50
Revenue / Employee
$445,891
Employees
477
Market Cap
106.30M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025212.69M3.33M1.59%
Dec 31, 2024209.36M22.24M11.89%
Dec 31, 2023187.12M45.28M31.92%
Dec 31, 2022141.84M47.42M50.22%
Dec 31, 202194.42M37.05M64.59%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Xtant Medical Holdings 133.08M
Neuronetics 129.87M
Pulmonx 90.50M
MaxCyte 34.42M
Baird Medical Investment Holdings 31.86M
Sensus Healthcare 27.48M
QT Imaging Holdings 18.93M
Hyperfine 10.59M
Revenue Rankings

TMCI News

More News